Seniors who take medications from a class of anti-anxiety drugs do not have an increased risk of dementia, research from the University of Washington has found.

The medications, known collectively as benzodiazepines, include Atvian, Valium and Xanax. They were previously thought to be associated with increased dementia risk.

The study’s authors say that while they have no tie to dementia risk, they still carry the risk of other side effects for seniors, including falls and confusion. Results of the study appeared in BMJ